AAP evidence review examines UTI treatment duration, route, and prophylaxis

This technical report synthesizes five systematic reviews and meta-analyses conducted to inform an updated AAP clinical practice guideline on pediatric urinary tract infection management. The review found low to very low certainty evidence overall, but suggested that antibiotic courses of 7 days or fewer may not increase recurrent UTI risk while reducing adverse events, oral therapy may be similarly effective to parenteral therapy, continuous antibiotic prophylaxis may not reduce breakthrough UTI or renal scarring but may increase antibiotic-resistant UTI, and evaluation within 72 hours of symptom onset may be associated with less renal scarring than later evaluation. The authors state these findings informed the updated AAP guideline recommendations.

Most relevant for: Clinicians managing children with urinary tract infection, suspected UTI, vesicoureteral reflux, or bowel and bladder dysfunction.

Summary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.

Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.